Edgewise Therapeutics, Inc. (EWTX): Price and Financial Metrics
EWTX Price/Volume Stats
| Current price | $26.26 | 52-week high | $38.12 |
| Prev. close | $26.72 | 52-week low | $9.61 |
| Day low | $26.23 | Volume | 589,300 |
| Day high | $27.41 | Avg. volume | 979,536 |
| 50-day MA | $30.43 | Dividend yield | N/A |
| 200-day MA | $23.32 | Market Cap | 2.49B |
EWTX Stock Price Chart Interactive Chart >
Edgewise Therapeutics, Inc. (EWTX) Company Bio
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.
EWTX Price Returns
| 1-mo | -14.68% |
| 3-mo | -24.56% |
| 6-mo | 40.20% |
| 1-year | 68.87% |
| 3-year | 79.99% |
| 5-year | N/A |
| YTD | -1.65% |
| 2024 | 144.06% |
| 2023 | 22.37% |
| 2022 | -41.49% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...